Health Technology Assessment

Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris) for the treatment of severe sepsis in adults:a systematic review and economic evaluation

  • Type:
    Extended Research Article
  • Authors:
    Green C, Dinnes J, Takeda A, Shepherd J, Hartwell D, et al.
  • Journal:
    Health Technology Assessment
  • Issue:
    Volume: 9, Issue: 11
  • Published:
  • Citation:
    Green C, Dinnes J, Takeda A, Shepherd J, Hartwell D, et al. Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris) for the treatment of severe sepsis in adults:a systematic review and economic evaluation. Health Technol Assess 2005;9(11). https://doi.org/10.3310/hta9110
  • DOI:
    https://doi.org/10.3310/hta9110
Crossmark status check

Toolkit

View Award

The full text of this issue is available as a PDF document from the Toolkit section on this page

We are currently working on improvements to this feature. Please check back soon for updates